| Firm |
Analyst |
| Morgan Stanley
|
Steve Harr |
| Rodman & Renshaw
|
Michael King |
| Lazard Freres & Co. LLC
|
Joel Sendek |
Threshold Pharmaceuticals is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Threshold Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Threshold Pharmaceuticals or its management. Threshold Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.